Christine Ren-Fielding
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Christine Ren-Fielding has a total of 105 co-authors. Here are the top co-authors by number of shared publications:
- Manish Parikh
New York City Health and Hospitals/Bellevue Hospital Center, New York, NY, USA
4 shared publications - Akash Gujral
Department of Medicine, New York University Grossman School of Medicine, New York, New York, USA
2 shared publications - Babak J. Orandi
Department of Surgery New York University New York New York USA
2 shared publications - Collin J. Popp
Department of Population Health, Center for Healthful Behavior Change, Institute for Excellence in Health Equity, New York University Langone Health, United States
2 shared publications George Fielding
Division of Bariatric Surgery and Weight Management, Department of Surgery, NYU Grossman School of Medicine, New York, New York
2 shared publications- Holly Lofton
Department of Bariatric Surgery New York University Langone Health New York New York USA
2 shared publications
Latest Publications
- Open Access
- 30 October 2026
- Published by Wiley in Obesity Science & Practice
- Vol. 12 (6)
Brain and Cardiometabolic Effects of Major Weight Loss in People With Obesity: Preliminary Cohort Findings
Objective: Given the overlap between obesity‐related metabolic and vascular abnormalities and Alzheimer's disease (AD) risk factors, it is critical to determine whether weight loss improves brain and cardiovascular health. This study examined whether ≥ 40% excess‐weight loss is associated with improvements in cardiometabolic risk, brain structure, and cognition. Methods: The study was a longitudinal study of individuals with obesity undergoing metabolic and bariatric surgery or medical/behavioral weight‐loss treatment. Participants were classified at follow‐up as weight‐loss (WL; ≥ 40% excess‐weight loss) or non‐weight‐loss (nWL; < 40%). All completed medical evaluations, structural MRI, and cognitive testing at baseline and 1 year. Results: At 1 year, the WL group exhibited improvements in BMI, HbA1C, inflammatory, metabolic, and lipid profiles. MRI‐based volumetrics revealed increases in subcortical gray‐matter volume and preservation of AD‐vulnerable regions. Cognitive performance remained unchanged. Conclusions: Achieving ≥ 40% excess‐weight loss was associated with improvements in metabolic health and brain structure, including favorable subcortical volume increases. These findings underscore the potential of sustained weight reduction to mitigate risks linked to metabolic syndromes and neurodegeneration. Longer‐term follow‐up is warranted to determine whether continued metabolic improvements lead to detectable cognitive gains and additional brain‐health benefits beyond 1 year.
- 30 October 2026
- Published by Wiley in Obesity Science & Practice
- Vol. 12 (6)
Open AccessBrain and Cardiometabolic Effects of Major Weight Loss in People With Obesity: Preliminary Cohort Findings
Objective: Given the overlap between obesity‐related metabolic and vascular abnormalities and Alzheimer's disease (AD) risk factors, it is critical to determine whether weight loss improves brain and cardiovascular health. This study examined whether ≥ 40% excess‐weight loss is associated with improvements in cardiometabolic risk, brain structure, and cognition. Methods: The study was a longitudinal study of individuals with obesity undergoing metabolic and bariatric surgery or medical/behavioral weight‐loss treatment. Participants were classified at follow‐up as weight‐loss (WL; ≥ 40% excess‐weight loss) or non‐weight‐loss (nWL; < 40%). All completed medical evaluations, structural MRI, and cognitive testing at baseline and 1 year. Results: At 1 year, the WL group exhibited improvements in BMI, HbA1C, inflammatory, metabolic, and lipid profiles. MRI‐based volumetrics revealed increases in subcortical gray‐matter volume and preservation of AD‐vulnerable regions. Cognitive performance remained unchanged. Conclusions: Achieving ≥ 40% excess‐weight loss was associated with improvements in metabolic health and brain structure, including favorable subcortical volume increases. These findings underscore the potential of sustained weight reduction to mitigate risks linked to metabolic syndromes and neurodegeneration. Longer‐term follow‐up is warranted to determine whether continued metabolic improvements lead to detectable cognitive gains and additional brain‐health benefits beyond 1 year.
- 30 March 2026
- Published by Springer Nature in Obesity Surgery
- Vol. 36 (5) , 2433-2441
Resting Energy Expenditure and Metabolic Adaptation Following Sleeve Gastrectomy in Hispanic Adults with Obesity
- 30 March 2026
- Published by Springer Nature in Obesity Surgery
- Vol. 36 (5) , 2433-2441
Resting Energy Expenditure and Metabolic Adaptation Following Sleeve Gastrectomy in Hispanic Adults with Obesity
- 10 January 2025
- Published by Elsevier in Surgery for Obesity and Related Diseases
- Vol. 21 (7) , 784-791
One anastomosis gastric bypass versus Roux-en-Y gastric bypass as a revisional bariatric procedure: comparing 1-year postoperative outcomes
- 10 January 2025
- Published by Elsevier in Surgery for Obesity and Related Diseases
- Vol. 21 (7) , 784-791
One anastomosis gastric bypass versus Roux-en-Y gastric bypass as a revisional bariatric procedure: comparing 1-year postoperative outcomes
- 27 December 2024
- Published by Springer Nature
- p. 353-366
Adjustable Gastric Band Associated Complications
- 27 December 2024
- Published by Springer Nature
- p. 353-366
Adjustable Gastric Band Associated Complications
- Open Access
Cohort profile: study design and baseline characteristics of an observational longitudinal weight loss cohort and biorepository of patients undergoing sleeve gastrectomy in the USA
Purpose We developed a comprehensive sleeve gastrectomy (SG) weight loss study cohort and biorepository to uncover mechanisms, biomarkers and predictive factors of weight loss, weight maintenance and amelioration of obesity-related comorbidities. For this purpose, we collected psychosocial, anthropometric, clinical data and a variety of samples pre-surgery, intraoperatively and 1.5, 3, 12 and 24 months post-surgery. For longer-term assessment, the collection of psychosocial and anthropometric data was extended to 10 years. Here, we present in-depth characterisation of the cohort and detailed overview of study procedures as a foundation for future analyses. Participants We consented 647 participants between June 2017 and March 2020 from two bariatric surgery clinics in New York City—one major urban hospital and one private hospital. Of 355 participants who provided baseline data, 300 underwent SG. Of these, 79% are females with an average age of 38 years, 68% are Hispanic, 20% are non-Hispanic Black and 11% are non-Hispanic White. Findings to date We collected intraoperative adipose and stomach tissues from 282 patients and biosamples (blood, urine, saliva, stool) from 245 patients at 1.5 months, 238 at 3 month, 218 at 12 months and 180 at 24 months post-surgery. We are currently collecting anthropometric and psychosocial data annually until 10 years post-surgery. Data analysis is currently underway. Future plans Our future research will explore the variability in weight loss outcomes observed in our cohort, particularly among Black and Hispanic patients in comparison to their White counterparts. We will identify social determinants of health, metabolic factors and other variables that may predict weight loss success, weight maintenance and remission of obesity-related comorbidities. Additionally, we plan to leverage our biorepository for collaborative research studies. We will complete long-term follow-up data by December 2031. We plan to apply for funding to expand biosample collection through year 10 to provide insights into the mechanisms of long-term weight maintenance.
Open AccessCohort profile: study design and baseline characteristics of an observational longitudinal weight loss cohort and biorepository of patients undergoing sleeve gastrectomy in the USA
Purpose We developed a comprehensive sleeve gastrectomy (SG) weight loss study cohort and biorepository to uncover mechanisms, biomarkers and predictive factors of weight loss, weight maintenance and amelioration of obesity-related comorbidities. For this purpose, we collected psychosocial, anthropometric, clinical data and a variety of samples pre-surgery, intraoperatively and 1.5, 3, 12 and 24 months post-surgery. For longer-term assessment, the collection of psychosocial and anthropometric data was extended to 10 years. Here, we present in-depth characterisation of the cohort and detailed overview of study procedures as a foundation for future analyses. Participants We consented 647 participants between June 2017 and March 2020 from two bariatric surgery clinics in New York City—one major urban hospital and one private hospital. Of 355 participants who provided baseline data, 300 underwent SG. Of these, 79% are females with an average age of 38 years, 68% are Hispanic, 20% are non-Hispanic Black and 11% are non-Hispanic White. Findings to date We collected intraoperative adipose and stomach tissues from 282 patients and biosamples (blood, urine, saliva, stool) from 245 patients at 1.5 months, 238 at 3 month, 218 at 12 months and 180 at 24 months post-surgery. We are currently collecting anthropometric and psychosocial data annually until 10 years post-surgery. Data analysis is currently underway. Future plans Our future research will explore the variability in weight loss outcomes observed in our cohort, particularly among Black and Hispanic patients in comparison to their White counterparts. We will identify social determinants of health, metabolic factors and other variables that may predict weight loss success, weight maintenance and remission of obesity-related comorbidities. Additionally, we plan to leverage our biorepository for collaborative research studies. We will complete long-term follow-up data by December 2031. We plan to apply for funding to expand biosample collection through year 10 to provide insights into the mechanisms of long-term weight maintenance.
- 24 September 2023
- Published by Springer Nature
- p. 713-721
Minimally Invasive Surgery Principles
- 2 July 2022
- Published by Elsevier in Surgery for Obesity and Related Diseases
- Vol. 18 (9) , 1120-1133
American Society of Metabolic and Bariatric Surgery consensus statement on laparoscopic adjustable gastric band management
- 2 July 2022
- Published by Elsevier in Surgery for Obesity and Related Diseases
- Vol. 18 (9) , 1120-1133
American Society of Metabolic and Bariatric Surgery consensus statement on laparoscopic adjustable gastric band management
- Open Access
c-MAF dependent perivascular macrophages regulate diet induced metabolic syndrome
SUMMARY: Macrophages are an essential part of tissue development and physiology. Perivascular macrophages have been described in tissues and appear to play a role in development and disease processes, although it remains unclear what are the key features of these cells. Here, we identify a subpopulation of perivascular macrophages in several organs, characterized by their dependence on the transcription factor c-MAF, displaying non-conventional macrophage markers including LYVE1, Folate receptor 2 and CD38. Conditional deletion of c-MAF in macrophage lineages caused ablation of perivascular macrophages in the brain and altered muscularis macrophages program in the intestine. In the white adipose tissue (WAT), c-MAF deficient perivascular macrophages displayed an altered gene expression profile, which was linked to an increased vascular branching into the tissue. Upon feeding on high fat diet (HFD), mice with c-MAF deficient macrophages showed improved metabolic parameters compared to wild-type mice, including less weight gain, greater glucose tolerance and reduced inflammatory cell profile in WAT. These results define c-MAF as a central regulator of perivascular macrophages cell identity and transcriptional program in vivo and reveal a novel role for this tissue resident macrophage population in the regulation of metabolic syndrome.
Open Accessc-MAF dependent perivascular macrophages regulate diet induced metabolic syndrome
SUMMARY: Macrophages are an essential part of tissue development and physiology. Perivascular macrophages have been described in tissues and appear to play a role in development and disease processes, although it remains unclear what are the key features of these cells. Here, we identify a subpopulation of perivascular macrophages in several organs, characterized by their dependence on the transcription factor c-MAF, displaying non-conventional macrophage markers including LYVE1, Folate receptor 2 and CD38. Conditional deletion of c-MAF in macrophage lineages caused ablation of perivascular macrophages in the brain and altered muscularis macrophages program in the intestine. In the white adipose tissue (WAT), c-MAF deficient perivascular macrophages displayed an altered gene expression profile, which was linked to an increased vascular branching into the tissue. Upon feeding on high fat diet (HFD), mice with c-MAF deficient macrophages showed improved metabolic parameters compared to wild-type mice, including less weight gain, greater glucose tolerance and reduced inflammatory cell profile in WAT. These results define c-MAF as a central regulator of perivascular macrophages cell identity and transcriptional program in vivo and reveal a novel role for this tissue resident macrophage population in the regulation of metabolic syndrome.